Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Marie, Viala"'
Autor:
Marie Viala, Nelly Firmin, Célia Touraine, Stéphane Pouderoux, Manon Metge, Lobna Rifai, Gilles Romieu, Hélène de Forges, Lise Roca, Séverine Guiu, Véronique D’Hondt, William Jacot
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-11 (2021)
Abstract Background Changes in calcium metabolism and calcium urinary excretion during chemotherapy have not been thoroughly assessed in patients with early breast cancer (EBC), a population who frequently present vitamin D insufficiency. As hypercal
Externí odkaz:
https://doaj.org/article/a9465dceb5cd4ab6a2b1b1a256909fdf
Autor:
Fanny Leenhardt, Frédéric Fiteni, Ludovic Gauthier, Marie Alexandre, Séverine Guiu, Nelly Firmin, Stéphane Pouderoux, Marie Viala, Gerald Lossaint, Chloé Gautier, Caroline Mollevi, Matthieu Gracia, Celine Gongora, Litaty Mbatchi, Alexandre Evrard, William Jacot
Publikováno v:
Pharmaceutics, Vol 14, Iss 4, p 841 (2022)
Palbociclib is a good candidate for therapeutic drug monitoring (TDM) due to its narrow therapeutic range and frequency of toxicities, particularly high-grade neutropenia. In this prospective, bicentric clinical trial, we evaluated the palbociclib ex
Externí odkaz:
https://doaj.org/article/d52b956fb3394cc7bed5973cee308283
Autor:
Marie Viala, Akiko Chiba, Simon Thezenas, Laure Delmond, Pierre-Jean Lamy, Sarah L. Mott, Mary C. Schroeder, Alexandra Thomas, William Jacot
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-11 (2018)
Abstract Background There has been interest in the potential benefit of vitamin D (VD) to improve breast cancer outcomes. Pre-clinical studies suggest VD enhances chemotherapy-induced cell death. Vitamin D deficiency was associated with not attaining
Externí odkaz:
https://doaj.org/article/c44e02243bd44271820183c3f092b14b
Autor:
Clément Carbasse, Fanny Leenhardt, William Jacot, Caroline Perrier, Frederic Pinguet, Marie Viala
Publikováno v:
British Journal of Clinical Pharmacology. 88:3370-3377
Oral targeted therapies (OTTs) are widely used for cancer management. However, there is no consensus on OTT dose adaptation in older patients with cancer.This noninterventional, retrospective study was a real-life assessment of dose adaptation for si
Autor:
Gr間ory Ninot, Estelle Guerdoux, Fran鏾is Carbonnel, Kerstin Faravel, Ludovic Ismael, Fanny Leenhardt, B閍trice Lognos, Caroline Perrier, Laurent Philibert, Boris Tronc, Marie Viala
Publikováno v:
Oncologie. 24:605-612
Autor:
S Pouderoux, Léa Sinoquet, William Jacot, Marie Viala, Xavier Quantin, Catherine Alix-Panabières, Laure Cayrefourcq, Ludovic Gauthier
Publikováno v:
Clinical Chemistry. 67:1503-1512
Background In non-small cell lung cancer (NSCLC), analysis of programmed cell death ligand 1 (PD-L1) expression in circulating tumor cells (CTCs) is a potential alternative to overcome the problems linked to the tumor biopsy spatiotemporal heterogene
Autor:
Nelly Firmin, C. Touraine, Véronique D'Hondt, L. Roca, S Pouderoux, Hélène de Forges, Lobna Rifai, Séverine Guiu, Marie Viala, William Jacot, Gilles Romieu, Manon Metge
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-11 (2021)
BMC Cancer
BMC Cancer, BioMed Central, 2021, 21 (1), pp.815. ⟨10.1186/s12885-021-08563-4⟩
BMC Cancer
BMC Cancer, BioMed Central, 2021, 21 (1), pp.815. ⟨10.1186/s12885-021-08563-4⟩
Background Changes in calcium metabolism and calcium urinary excretion during chemotherapy have not been thoroughly assessed in patients with early breast cancer (EBC), a population who frequently present vitamin D insufficiency. As hypercalciuria is
Publikováno v:
Cancers. 15:2276
Immune checkpoint inhibitors (ICIs) have been a major breakthrough in solid oncology over the past decade. The immune system and the gut microbiota are involved in their complex mechanisms of action. However, drug interactions have been suspected of
Therapeutic Bayesian monitoring of sunitinib in two patients with impaired absorption or elimination
Autor:
D. Tosi, Fanny Leenhardt, Marie Viala, Litaty Mbatchi, Emmanuelle Samalin-Scalzi, Alexandre Evrard
Publikováno v:
Journal of Clinical Pharmacy and Therapeutics. 46:1182-1184
What is known and objective Sunitinib pharmacokinetics can be influenced by the physio-pathological conditions of individual patients. Therapeutic drug monitoring (TDM) helps to optimize efficacy and reduce the risk of adverse effects. We report on t
Autor:
Nelly Firmin, William Jacot, Céline Bourgier, Marian Gutowski, Séverine Guiu, Marie Viala, Aurélie Maran-Gonzalez, Marie Alexandre, Véronique D'Hondt
Publikováno v:
Cancer Management and Research. 11:10353-10373
The decision to administer adjuvant chemotherapy in treatment of early invasive breast cancer (EBC) is often complex, particularly for hormone receptor-positive (HR+) diseases, and current guidelines often classify these patients in an intermediate-r